Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...

The Telco Data Monetization Market is experiencing strong growth, reaching an estimated value of USD 5.2 billion in 2024 and projected to surge to USD 15.7 billion by 2033. This expansion reflects a ...